#EDCTP2 proposal approved by the European Parliament15 April 2014

With an overwhelming majority the European Parliament approved the #EDCTP2 proposal.

EVI extends hearty congratulations to Charles Mgone and his team.

TRANSVAC Roadmap now available02 April 2014

EVI is proud to announce that the TRANSVAC consortium has drafted a roadmap entitled Towards a European Vaccine R&D Infrastructure: A Roadmap for Success

Advanced Statistics Course, Uganda 16 - 17 June 201431 March 2014

The Medical Research Council/Uganda Virus Researh Institute, Research Unit on AIDS

Couse Title: Uganda Advanced Statistical Methods in Epidemiology
Date:  16 - 17 June 2014
Venue: Uganda Virus Research Institute (UVRI), Entebbe
Organisers: Johnathan Levin and Kathy Baisly, London School of Hygiene and Tropical Medicine

Inserm launchs tender for GMP manufacturing25 March 2014

The tender for the GMP manufacturing of the VAR2CSA protein has been published by Institut national de la santé et de la recherche médicale (Inserm).

Please follow the links below for the complete information on this public tender:

Summary of 2013 Rendez-Vous now available25 February 2014

The summary of 2013 Rendez-Vous is available together with the agenda, list of participants, biosketches of the speakers the presentations made available by the speakers.

"Searching for a universal flu vaccine"17 February 2014

A new article about EDUFLUVAC and other EU-funded projects working on a universal flu vaccine was published in Horizon, the EU Research & Innovation Magazine, February 2014.

Call for financial auditing services13 February 2014

EVI has issued a call for financial auditing services, deadline on or before 31 May 2014

EVI New Year Greetings31 December 2013

EVI sends seasonal greetings to all our partners, colleagues, friends past and present.

London School of Hygiene & Tropical Medicine is offering a short course10 December 2013


The overall aim of this short course is to provide an understanding of the methods used in the evaluation of vaccines, from early human trials through to assessment of population impact and policy.